Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Wf8nwa83re
2. G 207
3. G 207 [who-dd]
4. G207
5. G-207
6. 80156-87-2
7. 2136340-90-2
8. 162320-00-5
9. Unii-wf8nwa83re
10. Schembl12425118
11. Schembl24849964
12. Dtxsid70612659
13. Zugkfnycfbdwio-uhfffaoysa-n
14. (e)-1-(4-butylphenyl)-2-{4-[(e)-(4-propoxyphenyl)diazenyl]phenyl}diazene
| Molecular Weight | 400.5 g/mol |
|---|---|
| Molecular Formula | C25H28N4O |
| XLogP3 | 8.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 10 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 58.7 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 499 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in brain cancer.
G207, Cancer killing viruses are modified to make them utilizable as a therapeutic agent in human by switching off certain genes that normally enable the virus to multiply in healthy cells, which would destroy these cells. As a result of this genetic modification, the HSVs are able to reproduce in tumor cells solely, since only this offer an environment that compensates for the loss of the removed viral genes. Consequently, the virus is able to replicate in the tumor cells, selectively destroying them without harming healthy tissue.
ABOUT THIS PAGE
60
PharmaCompass offers a list of G207 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right G207 manufacturer or G207 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred G207 manufacturer or G207 supplier.
PharmaCompass also assists you with knowing the G207 API Price utilized in the formulation of products. G207 API Price is not always fixed or binding as the G207 Price is obtained through a variety of data sources. The G207 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A G207 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of G207, including repackagers and relabelers. The FDA regulates G207 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. G207 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A G207 supplier is an individual or a company that provides G207 active pharmaceutical ingredient (API) or G207 finished formulations upon request. The G207 suppliers may include G207 API manufacturers, exporters, distributors and traders.
G207 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of G207 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right G207 GMP manufacturer or G207 GMP API supplier for your needs.
A G207 CoA (Certificate of Analysis) is a formal document that attests to G207's compliance with G207 specifications and serves as a tool for batch-level quality control.
G207 CoA mostly includes findings from lab analyses of a specific batch. For each G207 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
G207 may be tested according to a variety of international standards, such as European Pharmacopoeia (G207 EP), G207 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (G207 USP).
